{"id":"W2787239315","doi":"10.3233/kca-170020","title":"Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)","year":2018,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Axitinib; Sorafenib; Renal cell carcinoma; Internal medicine; Oncology; Everolimus; Temsirolimus; Proportional hazards model; Targeted therapy; Retrospective cohort study; Urology; Surgery; Cancer; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038722,0.0002934611,0.0003665196,0.0001137309,0.00008286448,0.00004299047,0.0003407805,0.00006220709,0.002249164],"category_scores_gemma":[0.00029687,0.0001876512,0.0001269467,0.0002476935,0.0002176378,0.0001193801,0.0001099148,0.0003056993,0.0001645147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004031881,"about_ca_system_score_gemma":0.0008783158,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009027652,"about_ca_topic_score_gemma":0.00128058,"domain_scores_codex":[0.9977309,0.0001267196,0.000561236,0.0006003182,0.0006023473,0.0003784799],"domain_scores_gemma":[0.9981216,0.0002827678,0.0002132977,0.0008180108,0.0002260199,0.0003383654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01916683,0.001580526,0.1438784,0.00007539505,0.001067413,0.001970812,0.006389466,0.00005448635,0.2261468,0.0000965064,0.5788256,0.02074774],"study_design_scores_gemma":[0.03582608,0.00147738,0.1902698,0.0005127738,0.0004656911,0.00007377914,0.0004868008,0.002987468,0.5107567,0.0001997877,0.25634,0.0006037156],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.966716,0.001785399,0.00008486665,0.0198133,0.001046663,0.0007641985,0.00268761,0.00004012491,0.007061837],"genre_scores_gemma":[0.9836946,0.000582165,0.001540497,0.009086844,0.001387578,0.0001372592,0.001106451,0.0000445538,0.00242006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3224855,"threshold_uncertainty_score":0.9986629,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05521137413412077,"score_gpt":0.3092914079217557,"score_spread":0.2540800337876349,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}